Royalty Pharma plc

Royalty Pharma Misses on EPS — Stock Down Unknown%

Royalty Pharma reported a loss per share of $0.47, which was significantly below expectations. However, there is no information on stock reaction or revenue figures, leaving investors without a clear picture of the company's performance. The lack of guidance further adds uncertainty about future prospects.